Contact
searchSearch
HMP Global

Biosimilars Topic Center

Featured Article

Conference Coverage
Real-World Strategies for Implementing Biosimilars
04/12/2023
Hannah Musick
Speakers at AMCP 2023 discussed the current landscape of biosimilars from a payer perspective as well as lessons learned from health system biosimilar adoption. 
Speakers at AMCP 2023 discussed the current landscape of biosimilars from a payer perspective as well as lessons learned from health system biosimilar adoption. 
Speakers at AMCP 2023 discussed...
04/12/2023
First Report Managed Care
From First Report Managed Care
Conference Insider
Addressing and Understanding Challenges Linked With Adopting Biosimilars Into Practice
12/08/2020
In a session at ASHP Midyear 2020, Osama Abdelghany, PharmD, MHA, BCOP Yale New Haven Hospital, and David L Crosby, PharmD, BCOP, BCPS, Dartmouth-Hitchcock Health, provide a variety of clinical, operational, and payer coverage considerations...
In a session at ASHP Midyear 2020, Osama Abdelghany, PharmD, MHA, BCOP Yale New Haven Hospital, and David L Crosby, PharmD, BCOP, BCPS, Dartmouth-Hitchcock Health, provide a variety of clinical, operational, and payer coverage considerations...
In a session at ASHP Midyear...
12/08/2020
Pharmacy Learning Network
Quiz
Identifying Pharmacist Knowledge of a Medication Drug Type
11/24/2020
Based on recent data, pharmacists are more well-informed about which medication type—with more than 80% demonstrating solid knowledge of their safety, efficacy, compatibility, and costs?
Based on recent data, pharmacists are more well-informed about which medication type—with more than 80% demonstrating solid knowledge of their safety, efficacy, compatibility, and costs?
Based on recent data,...
11/24/2020
Pharmacy Learning Network
News
Most Pharmacists Show Good Grasp of Biosimilar Medications, Study Finds
11/20/2020
“Pharmacists, being the drug experts, need to be well aware of the applied handling of biosimilar medicines,” researchers wrote. “They are an integral educator, trailblazer, and advocate of biosimilar integration across all clinical settings.”
“Pharmacists, being the drug experts, need to be well aware of the applied handling of biosimilar medicines,” researchers wrote. “They are an integral educator, trailblazer, and advocate of biosimilar integration across all clinical settings.”
“Pharmacists, being the drug...
11/20/2020
Pharmacy Learning Network
Newsfeed
Biosimilar Infliximab Appears Effective in Crohn`s Disease
12/11/2018
An infliximab biosimilar appears to be safe and effective in infliximab-naive patients with Crohn's disease, according to a recent study.
An infliximab biosimilar appears to be safe and effective in infliximab-naive patients with Crohn's disease, according to a recent study.
An infliximab biosimilar appears...
12/11/2018
Pharmacy Learning Network
News
Etanercept Biosimilar is Effective, Well-Tolerated for Rheumatoid Arthritis
02/16/2018
A recent study examined the efficacy of a biosimilar for treating patients with rheumatoid arthritis who respond inadequately to methotrexate
A recent study examined the efficacy of a biosimilar for treating patients with rheumatoid arthritis who respond inadequately to methotrexate
A recent study examined the...
02/16/2018
Pharmacy Learning Network
News
Biosimilar Infliximab Appears Safe, Effective in IBD Patients
12/15/2017
Researchers examined the effectiveness of switching to a biosimilar version of a drug in patients with IBD. 
Researchers examined the effectiveness of switching to a biosimilar version of a drug in patients with IBD. 
Researchers examined the...
12/15/2017
Pharmacy Learning Network
News
Pharmacist Role in Promoting Proper Biosimilar Usage
12/14/2017
Evelyn Hermes-Desantis, PharmD, BCPS, recently discussed the many factors involved in managing biosimilars in the hospital setting and the role pharmacists play in promoting their appropriate use in the context of safe patient care.
Evelyn Hermes-Desantis, PharmD, BCPS, recently discussed the many factors involved in managing biosimilars in the hospital setting and the role pharmacists play in promoting their appropriate use in the context of safe patient care.
Evelyn Hermes-Desantis, PharmD,...
12/14/2017
Pharmacy Learning Network
News
FDA Approves Another Biosimilar for RA Drug
12/14/2017
The FDA has approved a biosimilar for multiple autoimmune diseases. 
The FDA has approved a biosimilar for multiple autoimmune diseases. 
The FDA has approved a...
12/14/2017
Pharmacy Learning Network
News
FDA Approves First Biosimilar for Breast, Stomach Cancer
12/01/2017
The FDA has approved a biosimilar for two types of cancer.
The FDA has approved a biosimilar for two types of cancer.
The FDA has approved a...
12/01/2017
Pharmacy Learning Network
News
The Challenges of Bringing Biosimilars to Market
11/21/2017
Edward Li, Pharm D, MPH, BCOP, a professor in the Department of Pharmacy Practice at the University of New England College of Pharmacy, explains how industry experts can help bring biosimilars to the market faster.
Edward Li, Pharm D, MPH, BCOP, a professor in the Department of Pharmacy Practice at the University of New England College of Pharmacy, explains how industry experts can help bring biosimilars to the market faster.
Edward Li, Pharm D, MPH, BCOP, a...
11/21/2017
Pharmacy Learning Network

Newsfeed

News
Most Pharmacists Show Good Grasp of Biosimilar Medications, Study Finds
11/20/2020
“Pharmacists, being the drug experts, need to be well aware of the applied handling of biosimilar medicines,” researchers wrote. “They are an integral educator, trailblazer, and advocate of biosimilar integration across all clinical settings.”
“Pharmacists, being the drug experts, need to be well aware of the applied handling of biosimilar medicines,” researchers wrote. “They are an integral educator, trailblazer, and advocate of biosimilar integration across all clinical settings.”
“Pharmacists, being the drug...
11/20/2020
Pharmacy Learning Network
News
Etanercept Biosimilar is Effective, Well-Tolerated for Rheumatoid Arthritis
02/16/2018
A recent study examined the efficacy of a biosimilar for treating patients with rheumatoid arthritis who respond inadequately to methotrexate
A recent study examined the efficacy of a biosimilar for treating patients with rheumatoid arthritis who respond inadequately to methotrexate
A recent study examined the...
02/16/2018
Pharmacy Learning Network
News
Biosimilar Infliximab Appears Safe, Effective in IBD Patients
12/15/2017
Researchers examined the effectiveness of switching to a biosimilar version of a drug in patients with IBD. 
Researchers examined the effectiveness of switching to a biosimilar version of a drug in patients with IBD. 
Researchers examined the...
12/15/2017
Pharmacy Learning Network
News
Pharmacist Role in Promoting Proper Biosimilar Usage
12/14/2017
Evelyn Hermes-Desantis, PharmD, BCPS, recently discussed the many factors involved in managing biosimilars in the hospital setting and the role pharmacists play in promoting their appropriate use in the context of safe patient care.
Evelyn Hermes-Desantis, PharmD, BCPS, recently discussed the many factors involved in managing biosimilars in the hospital setting and the role pharmacists play in promoting their appropriate use in the context of safe patient care.
Evelyn Hermes-Desantis, PharmD,...
12/14/2017
Pharmacy Learning Network
News
FDA Approves Another Biosimilar for RA Drug
12/14/2017
The FDA has approved a biosimilar for multiple autoimmune diseases. 
The FDA has approved a biosimilar for multiple autoimmune diseases. 
The FDA has approved a...
12/14/2017
Pharmacy Learning Network
News
FDA Approves First Biosimilar for Breast, Stomach Cancer
12/01/2017
The FDA has approved a biosimilar for two types of cancer.
The FDA has approved a biosimilar for two types of cancer.
The FDA has approved a...
12/01/2017
Pharmacy Learning Network
News
The Challenges of Bringing Biosimilars to Market
11/21/2017
Edward Li, Pharm D, MPH, BCOP, a professor in the Department of Pharmacy Practice at the University of New England College of Pharmacy, explains how industry experts can help bring biosimilars to the market faster.
Edward Li, Pharm D, MPH, BCOP, a professor in the Department of Pharmacy Practice at the University of New England College of Pharmacy, explains how industry experts can help bring biosimilars to the market faster.
Edward Li, Pharm D, MPH, BCOP, a...
11/21/2017
Pharmacy Learning Network
News
Communication Needed to Improve Biosimilar Transition, Adherence
10/19/2017
Patients with rheumatoid arthritis, psoriatic arthritis, or ankylosing spondylitis who switched from an originator treatment to a biosimilar stopped taking the biosimilar medication within 6 months, a study showed. 
Patients with rheumatoid arthritis, psoriatic arthritis, or ankylosing spondylitis who switched from an originator treatment to a biosimilar stopped taking the biosimilar medication within 6 months, a study showed. 
Patients with rheumatoid...
10/19/2017
Pharmacy Learning Network
News
FDA Approves First Oncology Biosimilar
09/14/2017
The US Food and Drug Administration has approved the first biosimilar for the treatment of various cancers.
The US Food and Drug Administration has approved the first biosimilar for the treatment of various cancers.
The US Food and Drug...
09/14/2017
Pharmacy Learning Network
News
Update on FDA Biosimilar Guidance
08/08/2017
James Stevenson, PharmD, FASHP, discusses why pharmacists will shoulder much of the responsibility for ensuring providers understand and accept biosimilar therapies.
James Stevenson, PharmD, FASHP, discusses why pharmacists will shoulder much of the responsibility for ensuring providers understand and accept biosimilar therapies.
James Stevenson, PharmD, FASHP,...
08/08/2017
Pharmacy Learning Network
News
FDA Issues a Class II Recall of Prasugrel Tablets
03/26/2025
Juliet Gallagher
Mylan Pharmaceuticals Inc. has issued a voluntary Class II recall of Prasugrel Tablets, USP, 5 mg after routine testing revealed low dissolution results, indicating that affected tablets may not dissolve properly in the body.
Mylan Pharmaceuticals Inc. has issued a voluntary Class II recall of Prasugrel Tablets, USP, 5 mg after routine testing revealed low dissolution results, indicating that affected tablets may not dissolve properly in the body.
Mylan Pharmaceuticals Inc. has...
03/26/2025
Pharmacy Learning Network
News
Amgen Recalls Multiple Lots of Neupogen Due to Potential Stability Concerns
03/26/2025
Juliet Gallagher
Amgen Inc. has initiated a voluntary Class II recall of several lots of Neupogen (filgrastim) for injection, including both the 300 mcg/1 mL and 480 mcg/1.6 mL (300 mcg/mL) formulations.
Amgen Inc. has initiated a voluntary Class II recall of several lots of Neupogen (filgrastim) for injection, including both the 300 mcg/1 mL and 480 mcg/1.6 mL (300 mcg/mL) formulations.
Amgen Inc. has initiated a...
03/26/2025
Pharmacy Learning Network
News
Vitality Male Enhancement Supplement Recalled Due to Undeclared Drug Ingredients
03/26/2025
Juliet Gallagher
One Source Nutrition, Inc. has voluntarily recalled its product Vitality, fast acting male enhancement, distributed as both single capsule packets and bottles containing 6 capsules, due to the presence of undeclared pharmaceutical ingredients.
One Source Nutrition, Inc. has voluntarily recalled its product Vitality, fast acting male enhancement, distributed as both single capsule packets and bottles containing 6 capsules, due to the presence of undeclared pharmaceutical ingredients.
One Source Nutrition, Inc. has...
03/26/2025
Pharmacy Learning Network
News
ICU Medical Recalls Potassium Chloride Injection Due to Labeling Error
03/20/2025
Grace Taylor, MS, MA
ICU Medical, Inc has recalled potassium chloride injection (20 mEq in 100 mL) due to a labeling error that may misrepresent the product’s strength, posing a risk of dosing confusion.
ICU Medical, Inc has recalled potassium chloride injection (20 mEq in 100 mL) due to a labeling error that may misrepresent the product’s strength, posing a risk of dosing confusion.
ICU Medical, Inc has recalled...
03/20/2025
Pharmacy Learning Network
News
Breckenridge Pharmaceutical Recalls Duloxetine Capsules Due to Impurity Concerns
03/20/2025
Grace Taylor, MS, MA
Breckenridge Pharmaceutical has recalled Duloxetine Delayed-Release Capsules (60 mg) due to the presence of N-nitroso-duloxetine impurity exceeding US Food and Drug Administration limits.
Breckenridge Pharmaceutical has recalled Duloxetine Delayed-Release Capsules (60 mg) due to the presence of N-nitroso-duloxetine impurity exceeding US Food and Drug Administration limits.
Breckenridge Pharmaceutical has...
03/20/2025
Pharmacy Learning Network
News
Pitavastatin Tablets Recalled Due to Foreign Tablet Contamination
03/20/2025
Grace Taylor, MS, MA
A Class III recall has been initiated for Livalo (pitavastatin) tablets due to the presence of foreign tablets or capsules in the product.
A Class III recall has been initiated for Livalo (pitavastatin) tablets due to the presence of foreign tablets or capsules in the product.
A Class III recall has been...
03/20/2025
Pharmacy Learning Network
News
Study Finds RSV Positivity Not Linked to Higher Mortality in Adults With Acute Respiratory Illness
03/17/2025
Grace Taylor, MS, MA
Research from a Centers for Disease Control and Prevention (CDC)-supported surveillance network shows that respiratory syncytial virus (RSV) positivity in adults with acute respiratory illness is not associated with an increased risk of death...
Research from a Centers for Disease Control and Prevention (CDC)-supported surveillance network shows that respiratory syncytial virus (RSV) positivity in adults with acute respiratory illness is not associated with an increased risk of death...
Research from a Centers for...
03/17/2025
Pharmacy Learning Network
News
FDA Issues a Class II Recall of Ferrous Sulfate Oral Syringes
03/12/2025
Juliet Gallagher
Safecor Health, LLC has issued a voluntary nationwide recall of ferrous sulfate 7.5 mg iron/0.5 mL oral syringes due to a defective delivery system that may cause leakage after repackaging into unit-dose syringes.
Safecor Health, LLC has issued a voluntary nationwide recall of ferrous sulfate 7.5 mg iron/0.5 mL oral syringes due to a defective delivery system that may cause leakage after repackaging into unit-dose syringes.
Safecor Health, LLC has issued a...
03/12/2025
Pharmacy Learning Network
News
Simethicone Oral Syringes Recalled Due to Leakage Issue
03/12/2025
Juliet Gallagher
Safecor Health, LLC has issued a voluntary nationwide recall of simethicone 20 mg per 0.3 mL oral syringes due to a defective delivery system that may cause leakage after the solution is repackaged into unit-dose syringes.
Safecor Health, LLC has issued a voluntary nationwide recall of simethicone 20 mg per 0.3 mL oral syringes due to a defective delivery system that may cause leakage after the solution is repackaged into unit-dose syringes.
Safecor Health, LLC has issued a...
03/12/2025
Pharmacy Learning Network
News
Nelarabine Injection Recalled Due to Impurity and Degradation Concerns
03/12/2025
Juliet Gallagher
Zydus Pharmaceuticals (USA) Inc. has issued a nationwide voluntary recall of nelarabine injection, 250 mg/50 mL (5 mg/mL), citing failed impurities and degradation specifications as the reason for withdrawal.
Zydus Pharmaceuticals (USA) Inc. has issued a nationwide voluntary recall of nelarabine injection, 250 mg/50 mL (5 mg/mL), citing failed impurities and degradation specifications as the reason for withdrawal.
Zydus Pharmaceuticals (USA) Inc....
03/12/2025
Pharmacy Learning Network

Interactive Features

Quiz
Identifying Pharmacist Knowledge of a Medication Drug Type
11/24/2020
Based on recent data, pharmacists are more well-informed about which medication type—with more than 80% demonstrating solid knowledge of their safety, efficacy, compatibility, and costs?
Based on recent data, pharmacists are more well-informed about which medication type—with more than 80% demonstrating solid knowledge of their safety, efficacy, compatibility, and costs?
Based on recent data,...
11/24/2020
Pharmacy Learning Network

Stay Informed & Sign Up Today

Pharmacy Learning Network Newsletter

Video Insights

Videos
David Rubin, MD, on JAK Inhibitors: Small But Mighty
11/22/2023
David T. Rubin, MD
Dr Rubin reviews his presentation from the Advances in Inflammatory Bowel Disease regional meeting on the latest information on the safety and efficacy of Janus kinase inhibitors for the treatment of inflammatory bowel disease.
Dr Rubin reviews his presentation from the Advances in Inflammatory Bowel Disease regional meeting on the latest information on the safety and efficacy of Janus kinase inhibitors for the treatment of inflammatory bowel disease.
Dr Rubin reviews his...
11/22/2023
Pharmacy Learning Network
Videos
Advantages and Drawbacks of Lecanemab in Alzheimer Disease Treatment
11/10/2023
Paul Schulz, MD
Dr Shulz discusses the FDA-approved lecanemab for the treatment of AD.
Dr Shulz discusses the FDA-approved lecanemab for the treatment of AD.
Dr Shulz discusses the...
11/10/2023
Pharmacy Learning Network
Videos
Immunosuppressants or Immunomodulators? Biologic Agents for Psoriasis
10/27/2023
Ronald Vender, MD, FRCPC
In this exclusive interview, Dr Ronald Vender goes over the highly effective targeted biologic therapies used to treat psoriasis.
In this exclusive interview, Dr Ronald Vender goes over the highly effective targeted biologic therapies used to treat psoriasis.
In this exclusive interview, Dr...
10/27/2023
Pharmacy Learning Network
Videos
Application of Dupilumab to Pediatric Patients With Atopic Dermatitis
10/27/2023
Abigail Cline, MD, PhD
In this feature video, Dr Abigail Cline discusses current literature to assess reported efficacies, side effects, and risks of using dupilumab to treat atopic dermatitis in pediatric patients.
In this feature video, Dr Abigail Cline discusses current literature to assess reported efficacies, side effects, and risks of using dupilumab to treat atopic dermatitis in pediatric patients.
In this feature video, Dr...
10/27/2023
Pharmacy Learning Network
Videos
Patient Considerations When Prescribing Lecanemab for Alzheimer Disease
10/06/2023
Paul Schulz, MD
Dr Paul Schulz discusses the newly FDA-approved lecanemab for the treatment of AD.
Dr Paul Schulz discusses the newly FDA-approved lecanemab for the treatment of AD.
Dr Paul Schulz discusses the...
10/06/2023
Pharmacy Learning Network
Headshots of Chris Fausel, PharmD, MHA, BCOP; Erin Hamai Tom, PharmD, APh, MBA, BCACP; and Ryan Nix, PharmD, MMHC
Videos
Specialty Pharmacy Next: Focus on Distribution Processes, Data Utilization, New Drugs, and More
07/18/2023
Chris Fausel, PharmD, MHA, BCOP; Erin Hamai Tom, PharmD, APh, MBA, BCACP; Ryan Nix, BS, NRP, NCI
In this roundtable, cochairs of Specialty Pharmacy Next gather to discuss pertinent topics on the agenda such as white and brown bagging practices and data usage for program growth, as well as who may benefit most from attending the meeting.
In this roundtable, cochairs of Specialty Pharmacy Next gather to discuss pertinent topics on the agenda such as white and brown bagging practices and data usage for program growth, as well as who may benefit most from attending the meeting.
In this roundtable, cochairs of...
07/18/2023
Pharmacy Learning Network
Videos
Leaders in Pharmacy Come Together to Discuss and Debate Oncology-Related Developments
06/28/2021
Julie Gould
Chris Fausel, PharmD, Val Adams, PharmD, Kirollos Hanna, PharmD, and Lisa Holle, PharmD, cochairs of Great Debates and Updates Oncology Pharmacy, come together to discuss this new CPE event aimed at educating pharmacists interested in...
Chris Fausel, PharmD, Val Adams, PharmD, Kirollos Hanna, PharmD, and Lisa Holle, PharmD, cochairs of Great Debates and Updates Oncology Pharmacy, come together to discuss this new CPE event aimed at educating pharmacists interested in...
Chris Fausel, PharmD, Val Adams,...
06/28/2021
Pharmacy Learning Network
Expanded FDA Approval Improves Care Access, Rates of Flu Cases
Videos
Expanded FDA Approval Improves Care Access, Rates of Flu Cases
04/19/2021
Gregg Sylvester, MD, MPH, chief medical officer, and David Ross, vice president, commercial operations for North America, both at Seqirus, discuss the recent FDA approval for Flucelvax Quadrivalent, explain what the expanded indication means...
Gregg Sylvester, MD, MPH, chief medical officer, and David Ross, vice president, commercial operations for North America, both at Seqirus, discuss the recent FDA approval for Flucelvax Quadrivalent, explain what the expanded indication means...
Gregg Sylvester, MD, MPH, chief...
04/19/2021
Pharmacy Learning Network
Identifying Drug Diversion Differences in Retail Pharmacies Compared With Health Systems
Videos
Identifying Drug Diversion Differences in Retail Pharmacies Compared With Health Systems
12/28/2020
Tom Knight, founder and CEO, Invistics, identifies drug diversion differences in a hospital or health system versus a retail pharmacy, and explains what retail pharmacies can do to better detect and address drug diversion.
Tom Knight, founder and CEO, Invistics, identifies drug diversion differences in a hospital or health system versus a retail pharmacy, and explains what retail pharmacies can do to better detect and address drug diversion.
Tom Knight, founder and CEO,...
12/28/2020
Pharmacy Learning Network
Identifying Risks of Human Error, Workarounds in Pharmacy
Videos
Identifying Risks of Human Error, Workarounds in Pharmacy
12/22/2020
Matthew Grissinger, RPh, FISMP, FASCP, director of Error Reporting Programs, Institute for Safe Medication Practices, discusses how human error, various at-risk behaviors, as well as workarounds taken by staff members all impact outcomes and...
Matthew Grissinger, RPh, FISMP, FASCP, director of Error Reporting Programs, Institute for Safe Medication Practices, discusses how human error, various at-risk behaviors, as well as workarounds taken by staff members all impact outcomes and...
Matthew Grissinger, RPh, FISMP,...
12/22/2020
Pharmacy Learning Network

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2025 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use